Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Platelet-rich Plasma in Treatment of Melasma

NCT03674203 is registered in ClinicalTrials.gov with Instituto Mexicano del Seguro Social as lead sponsor.

NCT NCT03674203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03674203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Platelet-rich Plasma in Treatment of Melasma
Lead sponsor
Instituto Mexicano del Seguro Social
Phase
Phase 2
Overall status
Completed
Start date
May 1, 2017
Completion date
July 31, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma